157 related articles for article (PubMed ID: 15465348)
21. Slow-binding inhibition of gamma-aminobutyric acid aminotransferase by hydrazine analogues.
Lightcap ES; Silverman RB
J Med Chem; 1996 Feb; 39(3):686-94. PubMed ID: 8576911
[TBL] [Abstract][Full Text] [Related]
22. Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats.
Duboc A; Hanoteau N; Simonutti M; Rudolf G; Nehlig A; Sahel JA; Picaud S
Ann Neurol; 2004 May; 55(5):695-705. PubMed ID: 15122710
[TBL] [Abstract][Full Text] [Related]
23. May GABA transaminase inhibitors improve stereotyped behaviors in Rett syndrome?
Ghanizadeh A
Amino Acids; 2012 May; 42(5):2037-8. PubMed ID: 21344176
[No Abstract] [Full Text] [Related]
24. Design and mechanism of tetrahydrothiophene-based γ-aminobutyric acid aminotransferase inactivators.
Le HV; Hawker DD; Wu R; Doud E; Widom J; Sanishvili R; Liu D; Kelleher NL; Silverman RB
J Am Chem Soc; 2015 Apr; 137(13):4525-33. PubMed ID: 25781189
[TBL] [Abstract][Full Text] [Related]
25. The irreversible gamma-aminobutyrate transaminase inhibitor vigabatrin in the treatment of the alcohol withdrawal syndrome.
Stuppaeck CH; Deisenhammer EA; Kurz M; Whitworth AB; Hinterhuber H
Alcohol Alcohol; 1996 Jan; 31(1):109-11. PubMed ID: 8672169
[No Abstract] [Full Text] [Related]
26. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
Zwanzger P; Baghai TC; Schuele C; Ströhle A; Padberg F; Kathmann N; Schwarz M; Möller HJ; Rupprecht R
Neuropsychopharmacology; 2001 Nov; 25(5):699-703. PubMed ID: 11682253
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy.
Storici P; Capitani G; De Biase D; Moser M; John RA; Jansonius JN; Schirmer T
Biochemistry; 1999 Jul; 38(27):8628-34. PubMed ID: 10393538
[TBL] [Abstract][Full Text] [Related]
28. Human brain GABA transaminase tissue distribution and molecular expression.
Jeon SG; Bahn JH; Jang JS; Park J; Kwon OS; Cho SW; Choi SY
Eur J Biochem; 2000 Sep; 267(17):5601-7. PubMed ID: 10951220
[TBL] [Abstract][Full Text] [Related]
29. Bicyclic γ-amino acids as inhibitors of γ-aminobutyrate aminotransferase.
Pinto A; Tamborini L; Pennacchietti E; Coluccia A; Silvestri R; Cullia G; De Micheli C; Conti P; De Biase D
J Enzyme Inhib Med Chem; 2016; 31(2):295-301. PubMed ID: 25807299
[TBL] [Abstract][Full Text] [Related]
30. Effect of vigabatrin on contractile response to arachidonic acid and prostaglandins in smooth muscle preparations and platelet aggregation in experimental laboratory animals.
Raza M; Al-Shabanah OA
Pharmacol Res; 2003 Jun; 47(6):477-83. PubMed ID: 12742000
[TBL] [Abstract][Full Text] [Related]
31. Kinetic studies on the inhibition of GABA-T by gamma-vinyl GABA and taurine.
Sulaiman SA; Suliman FE; Barghouthi S
J Enzyme Inhib Med Chem; 2003 Aug; 18(4):297-301. PubMed ID: 14567543
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase.
Hawker DD; Silverman RB
Bioorg Med Chem; 2012 Oct; 20(19):5763-73. PubMed ID: 22944334
[TBL] [Abstract][Full Text] [Related]
33. Design and Mechanism of (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid, a Highly Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Addiction.
Juncosa JI; Takaya K; Le HV; Moschitto MJ; Weerawarna PM; Mascarenhas R; Liu D; Dewey SL; Silverman RB
J Am Chem Soc; 2018 Feb; 140(6):2151-2164. PubMed ID: 29381352
[TBL] [Abstract][Full Text] [Related]
34. Beta-lactams: a new class of conformationally-rigid inhibitors of gamma-aminobutyric acid aminotransferase.
Hopkins MH; Silverman RB
J Enzyme Inhib; 1992; 6(2):125-9. PubMed ID: 1284428
[TBL] [Abstract][Full Text] [Related]
35. Effect of maternal administration of vigabatrin during late gestation on fetoplacental amino acid profile in the mouse.
Abdulrazzaq YM; Padmanabhan R; Bastaki SM; Ibrahim A; Nurulain M; Shafiullah M
Reprod Toxicol; 2005; 20(4):549-60. PubMed ID: 15927444
[TBL] [Abstract][Full Text] [Related]
36. Vigabatrin for startle-disease with altered cerebrospinal-fluid free gamma-aminobutyric acid.
Stephenson JB
Lancet; 1992 Aug; 340(8816):430-1. PubMed ID: 1353584
[No Abstract] [Full Text] [Related]
37. Mechanism of inactivation of γ-aminobutyric acid aminotransferase by (1S,3S)-3-amino-4-difluoromethylene-1-cyclopentanoic acid (CPP-115).
Lee H; Doud EH; Wu R; Sanishvili R; Juncosa JI; Liu D; Kelleher NL; Silverman RB
J Am Chem Soc; 2015 Feb; 137(7):2628-40. PubMed ID: 25616005
[TBL] [Abstract][Full Text] [Related]
38. Effects of vigabatrin, an irreversible GABA transaminase inhibitor, on ethanol reinforcement and ethanol discriminative stimuli in mice.
Griffin WC; Nguyen SA; Deleon CP; Middaugh LD
Behav Pharmacol; 2012 Apr; 23(2):178-90. PubMed ID: 22336593
[TBL] [Abstract][Full Text] [Related]
39. Effect of Vigabatrin on motor responses to transcranial magnetic stimulation: an effective tool to investigate in vivo GABAergic cortical inhibition in humans.
Pierantozzi M; Marciani MG; Palmieri MG; Brusa L; Galati S; Caramia MD; Bernardi G; Stanzione P
Brain Res; 2004 Nov; 1028(1):1-8. PubMed ID: 15518635
[TBL] [Abstract][Full Text] [Related]
40. Probing the steric requirements of the γ-aminobutyric acid aminotransferase active site with fluorinated analogues of vigabatrin.
Juncosa JI; Groves AP; Xia G; Silverman RB
Bioorg Med Chem; 2013 Feb; 21(4):903-11. PubMed ID: 23306054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
